Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Chronic Use of Opioids Before and After Total Knee Arthroplasty: A Retrospective Cohort Study.

Hansen CA, Inacio MC, Pratt NL, Roughead EE, Graves SE.

J Arthroplasty. 2016 Oct 4. pii: S0883-5403(16)30686-6. doi: 10.1016/j.arth.2016.09.040. [Epub ahead of print]

PMID:
27836577
2.

Heart failure after conventional metal-on-metal hip replacements.

Gillam MH, Pratt NL, Inacio MC, Roughead EE, Shakib S, Nicholls SJ, Graves SE.

Acta Orthop. 2016 Oct 19:1-9. [Epub ahead of print]

PMID:
27759468
3.

Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis.

Roughead EE, Chan EW, Choi NK, Griffiths J, Jin XM, Lee J, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Wong IC, Yang YK, Pratt NL.

Expert Opin Drug Saf. 2016 Dec;15(12):1589-1595.

PMID:
27645304
4.

Response to Letter to the Editor: 'Use of preoperative comorbidity scores to predict mortality after total arthroplasty'.

Inacio MC, Pratt NL, Roughead EE, Graves SE.

Osteoarthritis Cartilage. 2016 Sep 9. pii: S1063-4584(16)30270-9. doi: 10.1016/j.joca.2016.09.003. [Epub ahead of print] No abstract available.

PMID:
27616681
5.

Increased risk of hospital admission for dehydration or heat-related illness after initiation of medicines: a sequence symmetry analysis.

Kalisch Ellett LM, Pratt NL, Le Blanc VT, Westaway K, Roughead EE.

J Clin Pharm Ther. 2016 Oct;41(5):503-7. doi: 10.1111/jcpt.12418.

PMID:
27378245
7.

Evaluation of three co-morbidity measures to predict mortality in patients undergoing total joint arthroplasty.

Inacio MC, Pratt NL, Roughead EE, Graves SE.

Osteoarthritis Cartilage. 2016 Oct;24(10):1718-26. doi: 10.1016/j.joca.2016.05.006.

PMID:
27188683
8.

Biomechanical fixation properties of cortical versus transpedicular screws in the osteoporotic lumbar spine: an in vitro human cadaveric model.

Sansur CA, Caffes NM, Ibrahimi DM, Pratt NL, Lewis EM, Murgatroyd AA, Cunningham BW.

J Neurosurg Spine. 2016 Oct;25(4):467-476.

PMID:
27176113
9.

Postoperative opioid use as an early indication of total hip arthroplasty failure.

Namba RS, Inacio MC, Pratt NL, Graves SE, Roughead EE, Craig Cheetham T, Paxton EW.

Acta Orthop. 2016 Jul;87 Suppl 1:37-43. doi: 10.1080/17453674.2016.1181820.

10.

Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study.

Inacio MC, Hansen C, Pratt NL, Graves SE, Roughead EE.

BMJ Open. 2016 Apr 29;6(4):e010664. doi: 10.1136/bmjopen-2015-010664.

11.

Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia.

Kalisch Ellett LM, Pratt NL, Ramsay EN, Sluggett JK, Barratt JD, Roughead EE.

J Am Med Dir Assoc. 2016 Jun 1;17(6):530-4. doi: 10.1016/j.jamda.2016.02.008.

PMID:
27052560
12.

Opioid use after total hip arthroplasty surgery is associated with revision surgery.

Inacio MC, Pratt NL, Roughead EE, Paxton EW, Graves SE.

BMC Musculoskelet Disord. 2016 Mar 10;17:122. doi: 10.1186/s12891-016-0970-6.

13.

Uptake of novel oral anticoagulants in Australia.

Pratt NL, Ramsay EN, Caughey GE, Shakib S, Roughead EE.

Med J Aust. 2016 Feb 15;204(3):104-5.e1. No abstract available.

PMID:
26866544
14.

Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database.

Wahab IA, Pratt NL, Ellett LK, Roughead EE.

Drug Saf. 2016 Apr;39(4):347-54. doi: 10.1007/s40264-015-0391-8.

PMID:
26798053
15.

Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation.

Inacio MC, Pratt NL, Roughead EE, Graves SE.

BMC Musculoskelet Disord. 2015 Dec 10;16:385. doi: 10.1186/s12891-015-0835-4.

16.

Commitment questions targeting patients promotes uptake of under-used health services: Findings from a national quality improvement program in Australia.

Pratt NL, Kalisch Ellett LM, Sluggett JK, Ramsay EN, Kerr M, LeBlanc VT, Barratt JD, Roughead EE.

Soc Sci Med. 2015 Nov;145:1-6. doi: 10.1016/j.socscimed.2015.09.019.

PMID:
26432175
17.
18.

Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.

Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Griffiths J, Wong IC, Yang YH, Pratt NL.

Drug Saf. 2015 Sep;38(9):823-31. doi: 10.1007/s40264-015-0318-4.

19.

Using Medications for Prediction of Revision after Total Joint Arthroplasty.

Inacio MC, Pratt NL, Roughead EE, Graves SE.

J Arthroplasty. 2015 Dec;30(12):2061-70. doi: 10.1016/j.arth.2015.06.009.

PMID:
26190569
20.

Response to Lertxundi and colleagues.

Kalisch Ellett LM, Pratt NL, Ramsay EN, Barratt JD, Roughead EE.

J Am Geriatr Soc. 2015 May;63(5):1054-5. doi: 10.1111/jgs.13418. No abstract available.

PMID:
25989587
Items per page

Supplemental Content

Loading ...
Support Center